Firms

PMV (Participatiemaatschappij Vlaanderen)
Brussels, Belgium · Flanders, Belgium
Participatiemaatschappij Vlaanderen NV, publicly branded PMV, is the Flemish government investment and financing institution, legal Belgian enterprise BE0455.777.660, headquartered at Oude Graanmarkt63 in Brussels. The statutory company was formed July31,1995; the present independent financing platform dates from2001 and celebrated its25-year operating anniversary in2026. PMV combines direct equity, loans, guarantees, fund commitments and strategic infrastructure investments to support companies with a meaningful Flemish connection from startup through international growth. Digital technology, life sciences and care, energy transition, industrial innovation and real estate are among its mandates. General Manager Michel Casselman and Chairman Koen Kennis are confirmed by the current2026 report and own directory. The complete live public directory names213 people across operating, governance, investment, credit, legal, support and specifically labelled related fund-management teams; these213 published affiliations are not a claim that all are direct investment professionals or an employee headcount. The audited2025 report separately counts188 employees. Named original portraits are available for197 of these people;16 lack recoverable original assets. Shared existing people, external board roles and authentic prior portraits are preserved. PMV owns but is legally distinct from PMV Fund Management NV, a separately governed manager. Its current affiliated funds include PMF Infrastructure Fund, EPICo I, EPICo II, Welvaartsfonds and Invest for Jobs, whose management transferred to that subsidiary in June2025. Those are not silently reassigned as parent-managed funds or parent cash investments. Welvaartsfonds completed aEUR167M first commitment close inAugust2021 and reachedEUR205M with a second close announced December1,2021; these completed committed fund sizes differ from paid drawn capital. A government answer separately reports onlyEUR48.8M paid of PMV ownEUR80M commitment. The earlierEUR500M policy target andEUR240M government allocation are not recorded as actual fund closes. PMV also performs fiduciary and operational management of the Flemish government’s Flanders Future Techfund, while separately owned Biotechfonds Vlaanderen and ARKimedes vehicles retain their own legal buyer attribution. The2025 annual report showsEUR4.7646B advised/managed assets and aEUR2.553634455B December5,2025 corporate capital increase connected to Brussels Airport; AUM, balance-sheet subscribed capital and uncalled capital are not new LP fund closes or automatically paid investment tickets. Primary own reMYND evidence confirms an earlier convertible loan and later2018/2021 equity participations; related2022 syndicate members remain unpublished. PMV Pharma is an unrelated US biotechnology company and is left untouched.
- Founded
- 1995
- Type
- Venture capital





















































































































































































































